Profile of:

Nelly Ziade

Dr. Nelly Ziadé Zoghbi is a consultant rheumatologist at Hotel-Dieu de France Hospital and Assistant Professor of Rheumatology, Public Health, and Epidemiology at Saint-Joseph University, Beirut. Dr. Ziadé holds an MD degree and a Rheumatology specialist degree from Saint-Joseph University, Beirut. She earned an MPH and a PhD degree in Public Health from Paris Universities. She has been elected as Fellow of the Royal College of Physicians of London. Dr. Ziadé is the president of the ArLAR Research Group (the ARCH), a board member of the Lebanese Society of Rheumatology, a member of the French Society of Rheumatology and a full ASAS member. Dr. Ziadé’s main clinical research interests target epidemiology, spondyloarthritis, telehealth, patient education, and juvenile idiopathic arthritis. She has more than 100 publications in peer-reviewed international journals and serves as an editorial board member and reviewer in several medical scientific journals.

Full name: Nelly Ziade

Current country: Lebanon

Membership level: Full

Type of membership: Member

Number of publications: 29

How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international study (2023)

Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey (2023)

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2023)

Diagnostic value of the anti-CD74 antibodies for axial spondyloarthritis: Results of a prospective study in patients with suspicious low back pain (2023)

Human leucocyte antigen-B27 testing in clinical practice: a global perspective (2023)

Peripheral spondyloarthritis: What have we learned? (2023)

The rheumatology workforce in the Arab countries: current status, challenges, opportunities, and future needs from an ArLAR cross-sectional survey (2023)

What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study (2023)

What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back pain (2022)

Women in Rheumatology in the Arab League of Associations for Rheumatology Countries: A Rising Workforce (2022)

Peripheral spondyloarthritis and psoriatic arthritis sine psoriase: are we dealing with semantics or clinically meaningful differences? (2022)

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines (2021)

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)

Individual and country-level socioeconomic factors and health outcomes in spondyloarthritis: analysis of the ASAS perSpA study (2021)

Root Joint Involvement in Spondyloarthritis: A Post-hoc Analysis from the International ASAS-PerSpA Study (2021)

Prospective correlational time-series analysis of the influence of weather and air pollution on joint pain in chronic rheumatic diseases (2021)

Establishing a sorting protocol for healthcare databases (2021)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries (2021)

Update of imaging in the diagnosis and management of axial spondyloarthritis (2020)

Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study (2020)

What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis? (2020)

Structural progression in axial spondyloarthritis (2020)

The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study (2020)

Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries (2020)

Tapering bDMARDs in axial SpA – what is the current evidence? (2019)

Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence (2019)

HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study (2019)

HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps (2017)